Total Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
GIC
IHL
EAM
Total Investment Management's IBB Position: Q2 2026 in Review
Total Investment Management opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,178 shares worth $220K. The stake represents 0.02% of the portfolio and ranks #80 among its holdings. This is a return to the name: Total Investment Management previously reported a position in IBB as recently as Q2 2025.
Total Investment Management first reported a position in IBB in Q2 2020 and has held it in 17 quarters since. The position peaked at $54.1M in Q2 2021. 451 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Total Investment Management held 1,178 shares of iShares Biotechnology ETF worth $220K as of Q2 2026.
- iShares Biotechnology ETF was a new Total Investment Management position in Q2 2026.
- iShares Biotechnology ETF made up 0.02% of Total Investment Management's portfolio in Q2 2026, its #80 holding.
- Total Investment Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 17 quarters since.
- Total Investment Management's iShares Biotechnology ETF position peaked at $54.1M in Q2 2021.
- 451 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Total Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.